Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-05 @ 5:00 AM
Study NCT ID:
NCT01317966
Status:
WITHDRAWN
Last Update Posted:
2016-04-20
First Post:
2011-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
Sponsor:
Ming Hou
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-03
Completion Date Type:
ESTIMATED
First Submit Date:
2011-03-17
First Submit QC Date:
None
Study First Post Date:
2011-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-18
Last Update Post Date:
2016-04-20
Last Update Post Date Type:
ESTIMATED